• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.

作者信息

Schupp Jonas, Becker Mike, Günther Jeannine, Müller-Quernheim Joachim, Riemekasten Gabriela, Prasse Antje

机构信息

Medical Centre, University Hospital Freiburg, Freiburg, Germany.

出版信息

Eur Respir J. 2014 May;43(5):1530-2. doi: 10.1183/09031936.00131713.

DOI:10.1183/09031936.00131713
PMID:24789955
Abstract
摘要

相似文献

1
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis.血清CCL18可预测系统性硬化症的肺部疾病进展及死亡率。
Eur Respir J. 2014 May;43(5):1530-2. doi: 10.1183/09031936.00131713.
2
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis.血清 CC 趋化因子配体-18 可预测系统性硬化症的肺部疾病恶化。
Eur Respir J. 2011 Dec;38(6):1355-60. doi: 10.1183/09031936.00004711. Epub 2011 Jul 20.
3
The ambitious goal of validating prognostic biomarkers for systemic sclerosis-related interstitial lung disease.
J Rheumatol. 2013 Jul;40(7):1034-6. doi: 10.3899/jrheum.130549.
4
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.趋化因子 CCL18 水平高与系统性硬化症患者肺功能恶化、肺纤维化进展和生存降低有关。
Chest. 2016 Aug;150(2):299-306. doi: 10.1016/j.chest.2016.03.004. Epub 2016 Mar 18.
5
Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?CC趋化因子配体18的血清水平是否为预测放射性肺损伤（RILT）的生物标志物？
PLoS One. 2017 Sep 28;12(9):e0185350. doi: 10.1371/journal.pone.0185350. eCollection 2017.
6
Serum III procollagen, but not serum I procollagen, is predictive of lung involvement in systemic sclerosis.
Clin Exp Rheumatol. 1998 Jul-Aug;16(4):517-8.
7
CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.CCL18作为特发性间质性肺炎和系统性硬化症中肺纤维化活动的指标。
Arthritis Rheum. 2007 May;56(5):1685-93. doi: 10.1002/art.22559.
8
Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.在系统性硬化症中，树突状细胞受到 Toll 样受体 4 激动剂的刺激后，白细胞介素-10 的产生增强，这可能与 CCL18 的分泌有关。
Scand J Rheumatol. 2009;38(4):282-90. doi: 10.1080/03009740802572467.
9
Elevated circulating CA 15.3 levels in a subset of systemic sclerosis with severe lung involvement.
Arch Dermatol. 1998 May;134(5):645. doi: 10.1001/archderm.134.5.645.
10
Serum CCL23 levels are increased in patients with systemic sclerosis.系统性硬化症患者血清 CCL23 水平升高。
Arch Dermatol Res. 2011 Jan;303(1):29-34. doi: 10.1007/s00403-010-1078-8. Epub 2010 Sep 8.

引用本文的文献

1
Influence of metabolic factors on systemic sclerosis complicated with severe interstitial lung disease based on high-resolution computed tomography grading.基于高分辨率计算机断层扫描分级的代谢因素对系统性硬化症合并严重间质性肺病的影响
Clin Rheumatol. 2025 Apr;44(4):1617-1624. doi: 10.1007/s10067-025-07305-2. Epub 2025 Feb 15.
2
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention.针对肺纤维化进展：潜在机制、分子生物标志物及治疗干预概述
Life (Basel). 2024 Feb 6;14(2):229. doi: 10.3390/life14020229.
3
Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.
系统性硬皮病相关间质性肺病疾病严重程度、临床病程和结局的判断异质性：系统文献回顾。
RMD Open. 2023 Nov;9(4). doi: 10.1136/rmdopen-2023-003426.
4
Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers.间质性肺疾病的急性加重：聚焦生物标志物。
Int J Mol Sci. 2023 Jun 15;24(12):10196. doi: 10.3390/ijms241210196.
5
When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis.当天然抗体变得致病性时：自身抗体针对 G 蛋白偶联受体在系统性硬化症发病机制中的作用。
Front Immunol. 2023 Jun 8;14:1213804. doi: 10.3389/fimmu.2023.1213804. eCollection 2023.
6
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies.CCL18作为特发性炎性肌病患者间质性肺疾病（ILD）和进行性纤维化ILD的生物标志物
Diagnostics (Basel). 2023 May 12;13(10):1715. doi: 10.3390/diagnostics13101715.
7
Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关间质性肺病患者的特征和死亡风险因素。
Ann Med. 2023 Dec;55(1):663-671. doi: 10.1080/07853890.2023.2179659.
8
Assessment of disease outcome measures in systemic sclerosis.系统性硬化病的疾病结局评估。
Nat Rev Rheumatol. 2022 Sep;18(9):527-541. doi: 10.1038/s41584-022-00803-6. Epub 2022 Jul 20.
9
Pathogenesis of systemic sclerosis associated interstitial lung disease.系统性硬化症相关间质性肺病的发病机制。
J Scleroderma Relat Disord. 2020 Mar;5(2 Suppl):6-16. doi: 10.1177/2397198320903867. Epub 2020 Mar 5.
10
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease.基质金属蛋白酶-7 在硬皮病相关间质性肺疾病中的预后作用。
Eur Respir J. 2021 Dec 9;58(6). doi: 10.1183/13993003.01560-2021. Print 2021 Dec.